RÉSUMÉ
We examined gastric outlet obstruction (GOO) patients who received two weeks of strengthening pre-operative enteral nutrition therapy (pre-EN) through a nasal-jejenal feeding tube placed under a gastroscope to evaluate the feasibility and potential benefit of pre-EN compared to parenteral nutrition (PN). In this study, 68 patients confirmed to have GOO with upper-gastrointestinal contrast and who accepted the operation were randomized into an EN group and a PN group. The differences in nutritional status, immune function, post-operative complications, weight of patients, first bowel sound and first flatus time, pull tube time, length of hospital stay (LOH), and cost of hospitalization between pre-operation and post-operation were all recorded. Statistical analyses were performed using the chi square test and t-test; statistical significance was defined as p < 0.05. The success rate of the placement was 91.18% (three out of 31 cases). After pre-EN, the levels of weight, albumin (ALB), prealbumin (PA), and transferrin (TNF) in the EN group were significantly increased by pre-operation day compared to admission day, but were not significantly increased in the PN group; the weights in the EN group were significantly increased compared to the PN group by pre-operation day and day of discharge; total protein (TP), ALB, PA, and TNF of the EN group were significantly increased compared to the PN group on pre-operation and post-operative days one and three. The levels of CD3+, CD4+/CD8+, IgA, and IgM in the EN group were higher than those of the PN group at pre-operation and post-operation; the EN group had a significantly lower incidence of poor wound healing, peritoneal cavity infection, pneumonia, and a shorter first bowel sound time, first flatus time, and post-operation hospital stay than the PN group. Pre-EN through a nasal-jejunum feeding tube and placed under a gastroscope in GOO patients was safe, feasible, and beneficial to the nutrition status, immune function, and gastrointestinal function, and sped up recovery, while not increasing the cost of hospitalization.
Sujet(s)
Cicatrice/chirurgie , Nutrition entérale , Sténose du défilé gastrique/chirurgie , Intubation gastro-intestinale , Complications postopératoires/prévention et contrôle , Soins préopératoires , Tumeurs de l'estomac/chirurgie , Adulte , Chine/épidémiologie , Cicatrice/diagnostic , Cicatrice/économie , Coûts et analyse des coûts , Nutrition entérale/effets indésirables , Nutrition entérale/économie , Études de faisabilité , Femelle , Sténose du défilé gastrique/diagnostic , Sténose du défilé gastrique/économie , Coûts hospitaliers , Humains , Incidence , Intubation gastro-intestinale/effets indésirables , Intubation gastro-intestinale/économie , Jéjunum , Durée du séjour , Mâle , Adulte d'âge moyen , État nutritionnel , Nutrition parentérale/effets indésirables , Nutrition parentérale/économie , Complications postopératoires/économie , Complications postopératoires/épidémiologie , Complications postopératoires/thérapie , Soins préopératoires/économie , Pronostic , Tumeurs de l'estomac/diagnostic , Tumeurs de l'estomac/économie , Cicatrisation de plaieRÉSUMÉ
AIM: To examine the effect of aberrant methylation of the KISS1 promoter on the development of colorectal cancer (CRC) and to investigate reversing aberrant methylation of the KISS1 promoter as a potential therapeutic target. METHODS: KISS1 promoter methylation, mRNA expression and protein expression were detected by methylation-specific polymerase chain reaction (PCR), real-time quantitative PCR and Western blotting, respectively, in 126 CRC tissues and 142 normal colorectal tissues. Human CRC cells with KISS1 promoter hypermethylation and poor KISS1 expression were treated in vitro with 5-aza-2'-deoxycytidine (5-Aza-CdR). After treatment, KISS1 promoter methylation, KISS1 mRNA and protein expression and cell migration and invasion were evaluated. RESULTS: Hypermethylation of KISS1 occurred frequently in CRC samples (83.1%, 105/126), but was infrequent in normal colorectal tissues (6.34%, 9/142). Moreover, KISS1 methylation was associated with tumor differentiation, the depth of invasion, lymph node metastasis and distant metastasis (P < 0.001). KISS1 methylation was also associated with low KISS1 expression (P < 0.001). Furthermore, we observed re-expression of the KISS1 gene and decreased cell migration after 5-Aza-CdR treatment in a CRC cell line. CONCLUSION: These data suggest that KISS1 is down-regulated in cancer tissues via promoter hypermethylation and therefore may represent a candidate target for treating metastatic CRC.
Sujet(s)
Marqueurs biologiques tumoraux/génétique , Tumeurs colorectales/génétique , Méthylation de l'ADN , Kisspeptines/génétique , Sujet âgé , Marqueurs biologiques tumoraux/métabolisme , Études cas-témoins , Mouvement cellulaire , Tumeurs colorectales/métabolisme , Tumeurs colorectales/anatomopathologie , Méthylation de l'ADN/effets des médicaments et des substances chimiques , DNA modification methylases/antagonistes et inhibiteurs , DNA modification methylases/métabolisme , Évolution de la maladie , Régulation négative , Antienzymes/pharmacologie , Femelle , Régulation de l'expression des gènes tumoraux , Cellules HCT116 , Humains , Kisspeptines/métabolisme , Mâle , Adulte d'âge moyen , Invasion tumorale , Régions promotrices (génétique) , ARN messager/métabolismeRÉSUMÉ
OBJECTIVE: To investigate the change of expression level of metastasis suppressor gene Kiss-1 in the colorectal cancer cell line SW480 after radiation, and to determine its association with the proliferation and apoptosis of SW480 cells. METHODS: SW480 cells were divided into control group (0 Gy) and study groups (2, 4, 6, 8 Gy). Cells in the study groups were irradiated by 6-MV X-ray radiation for 48 hours. Immunohistochemistry and real-time PCR methods were used to investigate the influence of radiation on Kiss-1 gene expression of SW480. Colony formation assay was used to detect the proliferation of SW480. Flow cytometry-Annexin- V/PI assay was used to observe the change of the apoptosis rate. RESULTS: Compared with the control group, Kiss-1 protein expression increased after radiation of 6, 8 Gy (P<0.05), but no significant changes were observed after radiation of 2, 4 Gy(P>0.05). Kiss-1 gene mRNA level increased after radiation of 2, 4, 6 Gy, while no obvious change was observed for 8 Gy radiation. The apoptosis rates increased for 4, 6, 8 Gy radiation(P<0.05), however, there was no significant difference for 2 Gy radiation (P<0.05). CONCLUSION: Radiation may increase Kiss-1 gene expression in SW480 cells, which results in decreases proliferation and increases apoptosis in residual surviving cells.
Sujet(s)
Apoptose , Prolifération cellulaire , Tumeurs colorectales/métabolisme , Kisspeptines/métabolisme , Lignée cellulaire tumorale , Tumeurs colorectales/anatomopathologie , Humains , Kisspeptines/génétique , Kisspeptines/effets des radiations , ARN messager/génétique , Rayons XRÉSUMÉ
BACKGROUND: Solid-pseudopapillary tumor of the pancreas (SPTP) is an uncommon and enigmatic pancreatic neoplasm that occurs mainly in young women. Although more and more cases have been reported in recent years, misdiagnosis and incorrect treatment still frequently take place. This study was designed to stimulate consideration of this tumor. METHODS: We retrospectively reviewed the experience of diagnosis and treatment of 15 patients with SPTP and compared them with 516 patients with pancreatic cancer from January 1997 to March 2007. RESULTS: Most of the SPTP cases were asymptomatic except for one palpable mass. Almost all SPTPs demonstrated a solid structure with hypo- or iso-attenuation, cystic structure with hypo-attenuation on pre-contrast CT scan, and enhancement of solid portions on post-contrast CT scan. By contrast, most cases of pancreatic carcinoma had multiple symptoms and abnormal blood results. The tumors showed hypo-attenuation on both pre-contrast and post-contrast CT scan, and only a few showed iso-attenuation on post-contrast CT scan. All cases of SPTP in our group were cured by surgical resection, while only 16.86% of patients with pancreatic carcinoma could undergo a radical resection. CONCLUSIONS: Clinical features and CT scans were helpful to differentiate SPTP from pancreatic carcinoma. Radical surgical resection was the most effective and safe method for the treatment of SPTP.
Sujet(s)
Carcinome papillaire/diagnostic , Tumeurs du pancréas/diagnostic , Adolescent , Adulte , Carcinome papillaire/chirurgie , Diagnostic différentiel , Femelle , Études de suivi , Humains , Mâle , Adulte d'âge moyen , Pancréatectomie/méthodes , Tumeurs du pancréas/chirurgie , Pronostic , Études rétrospectives , TomodensitométrieRÉSUMÉ
OBJECTIVE: To investigate the clinical characteristics,diagnosis and treatment of hepatoid adenocarcinoma of the stomach. METHODS: Clinical data of 13 hepatoid adenocarcinomas of the stomach, collected from 201 cases of gastric cancer, were analyzed retrospectively. RESULTS: Of the 201 gastric carcinomas, there were 13 AFP-producing adenocarcinomas of the stomach, the positive rate was 6.5%. Morphologically, the tumor cells formed glandular, medullary and linear structures. Of the 13 hepatoid adenocarcinomas of the stomach, 10 cases were in gastric antrum and 10 cases were poorly differentiated. The metastasis rates of liver and lymph node in hepatoid adenocarcinoma of stomach were higher than those in non-hepatoid adenocarcinoma of stomach. The treatment of hepatoid adenocarcinoma of stomach depended mainly on radical resection, and adjuvant chemotherapy was needed.The prognosis of hepatoid adenocarcinoma of stomach was poor. CONCLUSION: Hepatoid adenocarcinoma of the stomach has its own special tumor biological behavior and poor prognosis. Special attention should be paid to this disease.
Sujet(s)
Adénocarcinome/diagnostic , Adénocarcinome/thérapie , Tumeurs de l'estomac/diagnostic , Tumeurs de l'estomac/thérapie , Adénocarcinome/anatomopathologie , Adulte , Sujet âgé , Sujet âgé de 80 ans ou plus , Traitement médicamenteux adjuvant , Femelle , Gastrectomie , Humains , Mâle , Adulte d'âge moyen , Études rétrospectives , Tumeurs de l'estomac/anatomopathologie , Alphafoetoprotéines/métabolismeRÉSUMÉ
OBJECTIVE: To observe the effect of inhibition of serine/threonine kinase15 (STK15) gene expression on apoptosis induction in gastric cancer cell line-MKN45 and discuss the role of STK15 in viability of gastric cancer cells. METHODS: The STK15 expression was inhibited by chemically synthesized siRNA. The STK15 mRNA and protein level were respectively measured by real-time quantitative PCR and western blotting,the change of cell cycle distribution and apoptosis rate were detected by flow-cytometry, cell morphological change was observed by Hoechst staining,and pro-caspase 3 level was also detected by western blot. RESULTS: After treatment by siRNA targeting STK15 after 48 h, STK15 mRNA and protein level decreased obviously. More MKN45 cells accumulated at G(2)/M phase (P< 0.05). The apoptosis rate of STK15 siRNA treated MKN45 cells was higher than that of control cells(P< 0.05) with the pro-caspase 3 level decreased. CONCLUSIONS: Inhibition of STK15 gene expression may induce apoptosis in MKN45 cells through the pathway of caspase3. STK15 gene play a key role in proliferation and viability of MKN45 cells.
Sujet(s)
Apoptose , Extinction de l'expression des gènes , Protein-Serine-Threonine Kinases/génétique , Aurora kinase A , Aurora kinases , Lignée cellulaire tumorale , Régulation de l'expression des gènes tumoraux , Humains , Petit ARN interférent , Tumeurs de l'estomacRÉSUMÉ
OBJECTIVE: To observe the effect of polo-like kinase 1 (PLK1) gene depletion on mitosis phenotype and elucidate its vital role in gastric cancer cell line (MKN45) mitosis. METHODS: The PLK1 expression in MKN45 cells was blocked by RNA interference (RNAi), the expression level of PLK1 mRNA and protein were measured by real-time quantitative PCR and Western blot, respectively. The morphological change of microtubules and mitosis phenotype in MKN45 cells were observed by immunofluorescence staining and laser confocal microscopy, the morphological changes of cells were observed by reverse microscopy, the variation of cell cycle distribution was detected by flow-cytometry. RESULTS: After RNAi targeting PLK1, PLK1 mRNA and protein level decreased obviously, the cell microtubules became obscure and lost cohesiveness, the mitosis phenotype also varied substantially (P < 0.05), more gastric cancer cells became rounded and showed G(2) phase cell DNA content (P < 0.05). CONCLUSION: PLK1 gene plays a key role in mitosis and its inhibition can lead to mitosis arrest in MKN45 cells.
Sujet(s)
Protéines du cycle cellulaire/biosynthèse , Mitose/effets des médicaments et des substances chimiques , Protein-Serine-Threonine Kinases/biosynthèse , Protéines proto-oncogènes/biosynthèse , Interférence par ARN , Petit ARN interférent/pharmacologie , Tumeurs de l'estomac/métabolisme , Adénocarcinome/enzymologie , Adénocarcinome/métabolisme , Adénocarcinome/anatomopathologie , Protéines du cycle cellulaire/génétique , Lignée cellulaire tumorale , Phase G2/effets des médicaments et des substances chimiques , Humains , Protein-Serine-Threonine Kinases/génétique , Protéines proto-oncogènes/génétique , ARN messager/biosynthèse , ARN messager/génétique , Petit ARN interférent/génétique , Tumeurs de l'estomac/enzymologie , Tumeurs de l'estomac/anatomopathologie , Transfection ,RÉSUMÉ
OBJECTIVE: To investigate the role of STK15 in regulating mitosis of gastric cancer cells (MKN45) by gene silencing through RNA interference mechanism. METHODS: RNA interference technique was used to inhibit STK15 expression in MKN45 cells. The expression levels of STK15 mRNA and protein were measured by real-time quantitative RT-PCR and Western blot respectively and cell morphological changes were investigated by reverse microscopy. In addition, cell cycle distribution and cellular proliferation were determined by flow-cytometry and MTT assay respectively. Finally, the mitotic phenotype of MKN45 cells was studied by immunofluorescence staining and confocal microscopy. RESULTS: Silencing of STK15 gene by RNA interference was confirmed by marked decrease of STK15 mRNA and protein levels in the treated MKN45 cells. This silencing correlated with rounding of the cells, decreasing of DNA content in G(2) phase (P < 0.05) and a lowered proliferation index (P < 0.05), along with alterations of mitotic phenotype of MKN45 (P < 0.05). CONCLUSION: STK15 gene may play a key role in regulating cellular mitosis and its inhibition by RNA interference leading to mitosis arrest in MKN45 cells.
Sujet(s)
Extinction de l'expression des gènes , Mitose/effets des médicaments et des substances chimiques , Protein-Serine-Threonine Kinases/biosynthèse , Petit ARN interférent/pharmacologie , Tumeurs de l'estomac/métabolisme , Adénocarcinome/métabolisme , Adénocarcinome/anatomopathologie , Aurora kinase A , Aurora kinases , Cycle cellulaire/effets des médicaments et des substances chimiques , Lignée cellulaire tumorale , Prolifération cellulaire/effets des médicaments et des substances chimiques , ADN tumoral/métabolisme , Humains , Protein-Serine-Threonine Kinases/génétique , Interférence par ARN , ARN messager/biosynthèse , ARN messager/génétique , Tumeurs de l'estomac/anatomopathologieRÉSUMÉ
OBJECTIVE: To observe the effect of polo like kinase 1 (plk1) gene depletion on the growth of gastric cancer cell line-MKN45 cells in vitro and vivo and discuss the feasibility and effectiveness of arranging plk1 as gene therapeutic target for gastric cancer. METHODS: The plk1 expression of MKN45 cells was inhibited by RNA interference (RNAi). The plk1 mRNA and protein level were measured by real-time quantitative PCR and western blotting, and the change of cell cycle distribution and apoptosis rate were detected by flow-cytometry, and the MKN45 cells proliferation was measured by MTT method. MKN45 cells treated with plk1 siRNA were transplanted subcutaneously in nude mice and their tumorgenesis ability were observed, the plk1 protein levels of the samples from nude mice in different groups were compared. RESULTS: After treatment with plk1 siRNA, plk1 mRNA and protein level decreased obviously in certain time, more MKN45 cells accumulated at G(2)/M (P < 0.05). Apoptosis rate of MKN45 cells treated with plk1 siRNA was higher than that of control cells at 48 h and 72 h (P < 0.05), and MKN45 cells proliferated slowly than control groups (P < 0.05), while the tumorgenesis ability obviously decreased, but the plk1 protein levels of the samples from nude mice in different groups were not different. CONCLUSIONS: siRNA targeting plk1 can inhibit the proliferation of MKN45 cells in vitro and vivo. Plk1 may be a novel therapeutic target for gastric cancer.